Livagen 99% High peptide content white powder GLP/GLP-1 5mg 10mg 30mg customization
84 Inquiries
195875-84-4
Industrial Grade
99%
shenzhen
HTKT-Synpeptide
1 kilogram/gram per bag
Yes
2026-07-08
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceTesofensine ((1R, 2R, 3S, 5S)-3-(3, 4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane)) is an inhibitor of neuronal reuptake of dopamine, noradrenaline, and serotonin. Tesofensine was developed for the treatment of Alzheimer's and Parkinson's disease but lacked efficacy. Meta-analysis revealed that tesofensine (0.125–1.0 mg, once daily; oral) produced dose-dependent weight loss, and 32% of obese patients had ≥ 5% weight loss following 14 wk of treatment. Weight loss was accompanied by hypophagia, suggesting an appetite suppressant action[2].
Tesofensine is a dopamine, serotonin, and noradrenaline (triple) reuptake inhibitor originally developed by NeuroSearch for the treatment of Alzheimer's disease and Parkinson's disease. Development of the compound for these neurological indications was unsuccessful but significant weight loss was reported during the clinical trials in Parkinson's disease. Hence, tesofensine is now being developed by NeuroSearch for the treatment of obesity and type 2 diabetes[1].Research & Reference NoteLivagen 99% High peptide content white powder GLP/GLP-1 5mg 10mg 30mg customization is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
tesofensine
Other Name:(1S,3S,4R,5R)-3-(3,4-dichlorophenyl)-4-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane;(1R,2R,3S,5S)-3-(3,4-Dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane;Tesofensine-13C-d3;8-Azabicyclo[3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-, (1R,2R,3S,5S)-;Tesofensine 500mcg Tablets;Tesofensine 0.5mg Tablets
CAS No.:195875-84-4
Molecular Formula:C17H23Cl2NO
InChIKeys:VCVWXKKWDOJNIT-ZOMKSWQUSA-N
Molecular Weight:328.28
Exact Mass:328.28
UNII:BLH9UKX9V1
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.161±0.06 g/cm3(Predicted)
Boiling Point:396.6±42.0 °C(Predicted)
PKA:10.46±0.60(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide
-
Location:
No.2888 Sichuan Qingbaijiang Avenue
-
Average lead Time:
7 days
-
Year of Establishment:
2025
Company Certificates-
contact
-
contract
-
-
Inquiry History84 Inquiries
Country Product Purchase Quantity Date Posted
United Kingdom
tesofensine
100 PCS Oct 25, 2026
United States
tesofensine
10.0 G Oct 26, 2026
United Kingdom
tesofensine
10 G Oct 21, 2026
United Kingdom
tesofensine
1 G Oct 16, 2026
United Kingdom
tesofensine
100 G Oct 15, 2026
Spain
tesofensine
250 MG Oct 10, 2026
Australia
tesofensine
10 G Oct 9, 2026
United States
tesofensine tablet
10 MT Sep 27, 2026
United Kingdom
tesofensine
1 G Sep 23, 2026
Germany
CAS 195875-84-4 tesofensine
1000 MT Aug 21, 2026
United States
Tesofensine
15 G Aug 20, 2026
Philippines
Tesofenside tablet
10 MT Jul 29, 2026
United States
Tesofensine API
500 MG Jul 18, 2026
United States
Tesofensine
1 MT Jun 8, 2026
Belgium
Tesofensine
1000 PCS Jun 1, 2026
Belgium
Tesofensine
100 G May 31, 2026
United States
Tesofensine
1 G May 30, 2026
United States
Tesofensine
10 G May 27, 2026
United Kingdom
Tesofensine
1 G May 16, 2026
United Kingdom
Tesofensine
1 G May 10, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Acetyl tetrapeptide-3
Industrial Grade / 99%
$10-13/G FOB
-
-
-
-
PTD-DBM Acetate 99% High peptide content white powder GLP/GLP-1 5mg 10mg 30mg customization
Industrial Grade / 99%
$10-13/G FOB
-
-
-
-
SLU-PP-322 99% High peptide content white powder GLP/GLP-1 5mg 10mg 30mg customization
Industrial Grade / 99%
-
-
-
-
Oligopeptide-68
Industrial Grade / 99%
$10-13/G FOB
-
-
-
-
CBZ-Gly-Pro-pNA
Industrial Grade / 99%
$10-13/G FOB
-
-
-
-
gamma-DGG
/ 99%
-
